On Tuesday, Baba Ramdev’s Patanjali Ayurvedic Medicines launched anti-coronavirus drug ‘Coronil’. The drug was launched in a grand event. The company has claimed it to help control the spread of the virus.
The anti-coronavirus drug by Patanjali Ayurvedic Medicines was developed by the Patanjali Research Institute after holding various rounds of clinical trials at the NIMS University in Jaipur. The clinical trials were carried keeping the standardized protocols of drug discovery and have evaluated its efficacy. The company claims that the drug can cure all the coronavirus patients between 3 to 15 days of infection. The company also claims there would no mortality if the patient consumes the required dose of the drug.
In its press release, the company has suggested the treatment of COVID-19 patients between the ages of 15-80. For children, the company suggests taking half the dosage of adults. Further, as a part of the treatment, the company urged people to practice Yoga every morning in order to immune themselves from the coronavirus. ‘Coronil’ not only boosts the pulmonary system of the body but also strengthens the human physiology to counter the COVID-19 infection.
Patanjali Advises Other Medicines
The ingredients of Patanjali’s COVID-19 tablet Divya Coronil Tablet include Giloy, Tulsi and Ashwagandha. As for the dosage, the company advises taking the tablet thrice a day with hot water after breakfast, lunch, and dinner. Patanjali has also prescribed other medicines including Divya Swasari Vati, Patanjali Giloy Ghan Vati, Patanjali Ashwagandha Capsule, or Divya Ashwagandha Ghanvati, Patanjali Tulsi Ghanvati and Divya Anu Talia and Divya Swasari Vati.
The company has also advised people to consume Swasari Kwath, Ashwashila Capsule, Chyawanprash, Honey, Immunocharge, Aleo Vera Juice, Giloy Juice, Shilajit Capsule, 1-1 drop of Shilajit Sat and Haldi or even Patanjali pure Kesar with milk. In the event Baba Ramdev said,
“We have prepared the first Ayurvedic-clinically controlled, research, evidence & trial based medicine for COVID-19. We conducted a clinical case study & clinical controlled trial and found 69 percent of patients recovered in 3 days, and 100 percent of patients recovered in 7 days.”
The total number of cases in India has reached 4,41,070 out of which 1,78,714. 2,48,286 patients have recovered successfully in India.
Source: Republic World